So, someone decided to apply the same idea to deliver anti-nausea drugs to cancer patients after chemotherapy.

Several chemotherapeutic agents have proven to be useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease.

The drugs are used by about one million Americans a year, mostly people with anemia caused by cancer chemotherapy or kidney failure.